---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-086068"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2026-07-23T11:00:29+00:00"
generated_at: "2026-07-23T11:05:29.645365+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# United Therapeutics appoints Victor Dzau to Board of Directors

## Summary
- Board expanded to 13 members; Victor Dzau, M.D., appointed effective July 22, 2026.
- Dr. Dzau recently completed 12-year tenure as President of the National Academy of Medicine.
- Initial grant: 380 RSUs and 1,190 stock options; pro-rata grant: 350 RSUs and 1,110 options.
- No transactions exceeding $120,000 between Dr. Dzau and the company since last fiscal year.
- Dr. Dzau will not serve on any Board committee initially.

## SEC filing metadata
- accession: 0001104659-26-086068
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2026-07-23T11:00:29+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465926086068/0001104659-26-086068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465926086068/tm2620809d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-086068
- JSON: https://secwatch.observer/filing/0001104659-26-086068.json
- Plain text: https://secwatch.observer/filing/0001104659-26-086068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.